Omeros | OMER - Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
Adma Biologics USD 50.4M 8.24M 2025-12
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Cytokinetics USD 99.23M 13.32M 2025-09
Gilead Sciences USD 1.62B 50M 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 46.16M 15.25M 2025-12
Knight Therapeutics CAD 82.22M 1.03M 2025-12
MacroGenics USD 10.12M 34.18M 2025-12
Omeros USD 33.16M 18.52M 2024-06
Pacira USD 54.62M 6.02M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Rockwell Medical USD 21.28M 1.67M 2024-06
Sangamo BioSciences 2.42M 1.11M 2024-06
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
United Therapeutics USD 474.7M 373.8M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12
Xoma 116K 112.7K 2024-06